ALNYbenzinga

SVB Leerink Maintains Market Perform on Alnylam Pharmaceuticals, Lowers Price Target to $96

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 29, 2022 by benzinga

    SVB Leerink Maintains Market Perform on Alnylam Pharmaceuticals, Lowers Price Target to $96 | ALNY Stock News | Candlesense